Chelsea Delois
Nurse Practitioner · Port St Lucie, FLNPI 1548734825
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 218 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Inogen, Inc. at 35.6% of the total. 2025 is the largest year on record at $1,687, 2.8 times the $612 reported in 2022. Among nurse practitioner clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 218 payments — averaging $23.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inogen, Inc.$2K
- AstraZeneca$996
- GSK$517
- Inspire Medical Systems, Inc.$341
- Boehringer Ingelheim$311
- Verona Pharma, Inc.$203
- plus $948 from 13 others
What the payments were for
- Food & beverage$4,96997%
- Education$1803%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inogen, Inc. | 91 | $1,833 |
| AstraZeneca | 31 | $996 |
| GSK | 23 | $517 |
| Inspire Medical Systems, Inc. | 15 | $341 |
| Boehringer Ingelheim | 12 | $311 |
| Verona Pharma, Inc. | 8 | $203 |
| Regeneron Healthcare Solutions, Inc. | 6 | $202 |
| Insmed, Inc. | 10 | $186 |
| Actelion Pharmaceuticals US, Inc. | 2 | $106 |
| Sanofi | 3 | $87 |
| Caris MPI, Inc. | 2 | $57 |
| Baxter Healthcare | 3 | $56 |
| Lilly USA, LLC | 3 | $51 |
| Grifols USA, LLC | 3 | $49 |
| Mylan Specialty L.p. | 2 | $37 |
| Philips North America LLC | 1 | $33 |
| Novo Nordisk | 1 | $32 |
| Viatris Specialty LLC | 1 | $26 |
| Pulmonx Corporation | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$125
- TRELEGY ELLIPTA$125
- BREZTRI$125
How this compares
$5,148 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 366 | $337,230 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 110 | $70,379 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 76 | $44,228 |
| SymbicortBudesonide/Formoterol Fumarate | 132 | $38,115 |
| Breo ElliptaFluticasone/Vilanterol | 29 | $22,013 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 29 | $21,334 |
| Spiriva RespimatTiotropium Bromide | 18 | $16,169 |
| Advair HfaFluticasone Propion/Salmeterol | 15 | $9,959 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 213 | $8,967 |
| Incruse ElliptaUmeclidinium Bromide | 12 | $8,889 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 33 | $6,481 |
| BreynaBudesonide/Formoterol Fumarate | 17 | $4,175 |
| Ventolin HfaAlbuterol Sulfate | 12 | $1,035 |
| Roflumilast | 11 | $744 |
| Montelukast Sodium | 72 | $638 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $517 | $412,359483 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat | $311 | $86,548128 claims |
| AstraZenecaSymbicort, Breztri Aerosphere | $996 | $59,450161 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Port St Lucie
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.